Skip to Content

Decision Diagnostics Corp DECN

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

DECN is trading at a 25% discount.
Price
$0.00
Fair Value
$5.50
Uncertainty
Extreme
1-Star Price
$3.18
5-Star Price
$7.76
Economic Moat
Ncbghv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if DECN is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.01
Market Cap
$357.87
Volume/Avg
400 / 110,751

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Decision Diagnostics Corp is a provider of prescription drugs, home testing products for the chronically ill, direct to patient diabetes programs, and a developer of revolutionary, cell phone centric, e-health products and technology. The company also provides blood glucose home testing test strips and exciting new concepts for blood testing monitors.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Small Value
Total Number of Employees

Valuation

Metric
DECN
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
DECN
Quick Ratio
0.22
Current Ratio
0.25
Interest Coverage
−0.33
Quick Ratio
DECN

Profitability

Metric
DECN
Return on Assets (Normalized)
−138.03%
Return on Equity (Normalized)
−3,633.31%
Return on Invested Capital (Normalized)
−94.86%
Return on Assets
DECN
See how this stock stacks up to its competitors with Morningstar Investor

Pharmaceutical Retailers Industry Comparables

Sponsor Center